Your Messages Inbox
Most Viewed Abstracts
1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 2. Omega-3 fatty acids for bipolar disorder 3. Is folic acid good for everyone 4. ACS Releases Guidelines for HPV Vaccination 5. Vitamin D - A review Free full text
Your Article Summary
See Latest ArticlesElevation of plasma retinol-binding protein 4 and reduction of plasma adiponectin in subjects with cerebral infarction
Metabolism-Clinical and Experimental, 11/03/09
Sasaki M et al. – Hypoadiponectinemia is concomitantly involved in the pathogenesis of atherosclerosis, and that an elevation of plasma RBP4 may be a useful marker for the development of atherosclerosis, in subjects with cerebral infarction.
Related Articles
Menopause impacts the relation of plasma adiponectin levels with the metabolic syndrome
Journal of Internal Medicine, 11/17/09
Relevance Score: 69%
Enhanced insulin sensitivity after acute exercise is not associated with changes in high-molecular weight adiponectin concentration in plasma
European Journal of Endocrinology, 11/05/09
Relevance Score: 69%
Circulating Adiponectin: Associations with Risk Factors and the Reynolds Risk Score in Women without Prior Major Cardiovascular Events
Cardiology, 10/30/09
Relevance Score: 68%
Blockade of the RAS increases Plasma Adiponectin in Subjects with Metabolic Syndrome and Enhances Differentiation and Adiponectin Expression of Human Preadipocytes
Experimental and Clinical Endocrinology & Diabetes, 11/02/09
Relevance Score: 66%
Fasting and postprandial adiponectin alterations anticipate NEFA and TNF-alpha changes in prepubertal obese children
Nutrition, Metabolism & Cardiovascular Diseases, 10/26/09
Relevance Score: 66%
Today in Atherosclerosis/Lipids...keeping you current
Receive free subspecialty "5-minute updates" via email
Cardiovascular and Economic Outcomes After Initiation of Lipid-Lowering Therapy With Atorvastatin vs Simvastatin in an Employed Population
Mayo Clinic Proceedings, 12/11/09
Subclinical Atherosclerosis In Young beta-thalassemia Major Patients
Hemoglobin, 12/11/09
Year Two Assessment of Fenofibric Acid and Moderate-Dose Statin Combination: A Phase 3, Open-Label, Extension Study
Clinical Drug Investigation, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor